Ticker Details
X4 Pharmaceuticals Inc Arsanis Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of monoclonal antibodies for the targeted immunotherapy of serious infections.
IPO Date:	May 13, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.61M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 5.37%
Avg Daily Range (30 D):	$0.02 | 5.63%
Avg Daily Range (90 D):	$0.07 | 6.68%

Institutional Daily Volume
Avg Daily Volume:	.23M
Avg Daily Volume (30 D):	1.4M
Avg Daily Volume (90 D):	1.14M

Trade Size
Avg Trade Size (Sh.):	58
Avg Trade Size (Sh.) (30 D):	510
Avg Trade Size (Sh.) (90 D):	205

Institutional Trades
Total Institutional Trades:	10
Avg Institutional Trade:	$.93M
Avg Institutional Trade (30 D):	$2.54M
Avg Institutional Trade (90 D):	$2.54M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$.53M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	14.29K

News

Dec 18, 2025 @ 1:01 AM Actelis Networks Announces Pricing of $5 Million P... Source: Actelis Networks, Inc.

Jul 1, 2025 @ 12:00 PM Actelis Networks Announces Private Placement Price... Source: Actelis Networks, Inc.

May 14, 2025 @ 12:04 PM US Stock Futures Trade Higher On Wednesday: S&P 50... Source: Rishabh Mishra

May 14, 2025 @ 10:49 AM US Stock Futures Trade Lower On Wednesday: S&P 500... Source: Rishabh Mishra

Aug 14, 2024 @ 9:45 PM Actelis Networks Reports Q2 2024 Results: 372% Seq... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.17	$-.21	$-.22
Diluted EPS	$-.17	$-.21	$-.22
Revenue	$.64M	$.94M	$.72M
Gross Profit	$.18M	$.31M	$.25M
Net Income / Loss	$-1.98M	$-1.9M	$-1.86M
Operating Income / Loss	$-1.93M	$-1.77M	$-1.81M
Cost of Revenue	$.46M	$.64M	$.47M
Net Cash Flow	$1.06M	$-.73M	$-.84M
PE Ratio

Splits
Nov 18, 2025	1:10
Apr 19, 2023	1:10
Mar 14, 2019	1:6